Access cutting-edge gastric cancer treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.
Access gastric cancer specialists in Ann Arbor at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gastric cancer treatment provided free
Zolbetuximab is being studied in people with cancer in and around the stomach or where the food pipe (esophagus) joins the stomach, called gastroesophageal junction (GEJ) cancer. Zolbetuximab with chemotherapy may be used to treat stomach and GEJ cancer when the cancer cells do not have a protein called HER2 (human epidermal growth factor receptor 2) on their surface (HER2-negative) but do have a protein called Claudin 18.2 (Claudin 18.2-positive). Zolbetuximab is thought to work by attaching to
Sponsor: Astellas Pharma Global Development, Inc.
Check if you qualify for this gastric cancer clinical trial in Ann Arbor, MI
If you're searching for gastric cancer treatment options in Ann Arbor, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gastric cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.